Egle Bytautiene Prewit, M.D., Ph.D.
A native of Lithuania, Dr. Prewit received her MD at the Vilnius University, followed by a PhD in Clinical Sciences from the University of Texas Medical Branch (UTMB) in Galveston, Texas. From 1997-2018 she was a faculty in the Department of Obstetrics and Gynecology at UTMB. In May 2018, Dr. Prewit joined UT Health San Antonio in the Division of Reproductive Research in the Department of Obstetrics and Gynecology. The overarching goal of her research is to determine the mechanisms by which pregnancy and the postpartum period act as a window to the future maternal and child health. Her research concentrates on how pregnancy and its complications such as preterm birth, obesity and preeclampsia affect short and long-term maternal and fetal outcomes. Dr. Prewit is also studying the long-term maternal health benefits resulting from breastfeeding. Areas of particular interest are effect of statins on fetal inflammatory system after exposure to prenatal infection, oxytocin-oxytocin receptor and renin-angiotensin systems, effects of anti-diabetic medications on placenta and pregnancy outcomes.
- 2010 - Doctor of Philosophy - Biomedical Sciences - The University of Texas Medical Branch
- 1991 - Doctor of Medicine - Medicine - Vilnius University
- 1992 - Residency - Internal Medicine - Vilnius University
- 2018 - Assistant Professor/Research - The University of Texas Health Science Center
- 2013 - 2018 - Member - Institute of Translational Sciences
- 2011 - 2018 - Adjunct Assistant Professor - The University of Texas Medical Branch
- 2006 - 2011 - Instructor - The University of Texas Medical Branch
- 2006 - Senior Research Scientist - The University of Texas Medical Branch
- 2005 - 2006 - Visiting Scientist - Karolinska Institute, Huddinge University Hospital
- 2004 - 2005 - Research Investigator - The University of Texas Medical Branch
- 1997 - 2004 - Research Fellow - The University of Texas Medical Branch
- 1992 - 1997 - Researcher - Heartscan Inc.
Research & Grants
NIH 1R03HD097424-01 | 07/10/2019 - 06/30/2021 | Investigation into statins as prevention and treatment of inflammation in pregnancy
NIH 1R01HL140361-01A1 | 09/01/2019 08/31/2024 | Lactation, oxytocin and maternal cardiovascular function later in life
Ferring Pharmaceuticals Contract | 07/01/2016 – 06/30/2017 | Comparison of a novel peptide antagonist in a mouse overexpressing sFlt-1 as a model of preeclampsia
AHA Beginning-Grant-in-Aid 14BGIA20480229 | 07/01/2014 – 6/30/2017 | Lactation, oxytocin, and maternal cardiometabolic health later in life